FDA Must Maintain Conflict of Interest Waivers, Gottlieb Argues
This article was originally published in The Pink Sheet Daily
Executive Summary
The inability to issue conflict of interest waivers would diminish advisory panels’ importance to the agency, the Deputy Commissioner for Medical & Scientific Affairs said at an event on government panels.